QIAGEN N.V. (QGEN) SEC Filings & Financial Intelligence
QIAGEN N.V. (QGEN) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: QGEN
CIK: 1015820
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EY GmbH & Co. KG Wirtschaftspruefungsgesellschaft
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerAndreas Weigel
Audit LocationCologne, Germany
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-11-06 | — | SCHEDULE 13G/A Filing | 0000902219-26-000322 | View SEC Doc Filr Page |
| 6-K | 2026-11-06 | 2026-09-30 | 6-K | 0001015820-26-000063 | View SEC Doc Filr Page |
| 6-K | 2026-11-06 | 2026-09-30 | 6-K | 0001015820-26-000061 | View SEC Doc Filr Page |
| SC TO-C | 2026-10-28 | — | SC TO-C | 0001104659-26-119256 | View SEC Doc Filr Page |
| 6-K | 2026-10-23 | 2026-10-23 | FORM 6K | 0000950103-26-016060 | View SEC Doc Filr Page |
| SC TO-C | 2026-10-22 | — | SC TO-C | 0001104659-26-117921 | View SEC Doc Filr Page |
| SC14D9C | 2026-10-22 | — | FORM SC14D9C | 0000950103-26-015981 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-30 | 6-K | 0001015820-26-000056 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-06-30 | 6-K | 0001015820-26-000053 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-06-30 | 6-K | 0001015820-26-000049 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-06-30 | 6-K | 0001015820-26-000047 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0000912938-26-000674 | View SEC Doc Filr Page |
| SD | 2026-06-01 | — | SD | 0001015820-26-000035 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2026-03-31 | 6-K | 0001015820-26-000031 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2026-03-31 | 6-K | 0001015820-26-000029 | View SEC Doc Filr Page |
| 6-K | 2026-05-01 | 2026-03-31 | 6-K | 0001015820-26-000024 | View SEC Doc Filr Page |
| IRANNOTICE | 2026-03-20 | — | IRANNOTICE | 0001015820-26-000020 | View SEC Doc Filr Page |
| 20-F | 2026-03-20 | 2025-12-31 | 20-F | 0001015820-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-10 | — | SCHEDULE 13G/A Filing | 0000902219-26-000087 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-06 | — | SCHEDULE 13G Filing | 0002012383-26-000897 | View SEC Doc Filr Page |
| 6-K | 2026-02-06 | 2025-12-31 | 6-K | 0001015820-26-000003 | View SEC Doc Filr Page |
| 25-NSE/A | 2026-01-09 | — | 25-NSE/A Filing | 0000876661-26-000033 | View SEC Doc Filr Page |
| 25-NSE | 2026-01-08 | — | 25-NSE Filing | 0000876661-26-000016 | View SEC Doc Filr Page |
| 6-K | 2025-12-22 | 2025-12-31 | 6-K | 0001015820-25-000077 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-12 | — | SCHEDULE 13G/A Filing | 0000902219-25-000383 | View SEC Doc Filr Page |